Business
Progyny, Inc. Announces Fourth Quarter 2025 Results
Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating
About this update from Progyny, Inc.
[{"type":"text","content":"Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent AuthorizationIssues Financial Guidance for 2026, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced its financial results for the three- and twelve-month periods ended December 31, 2025 (“the fourth quarter of 2025” and \"the full year\", respectively), as compared to the three- and twelve-month periods ended December 31, 2024 (“the fourth quarter of 2024” and “the prior year period”, respectively). “We're pleased to report that 2025 ended strongly, concluding a record year for Progyny, one in which we achieved our highest ever levels of full year revenue, Adjusted EBITDA, and operating cash flow,” said Pete Anevski, Chief Executive Officer of Progyny. “These results reflect how our model provides us with the ability to both expand the business while simultaneously investing for future growth. As 2026 begins, we're excited for the significant opportunities ahead as we continue to expand our presence with large self-insured employers, both in the US and globally, while also launching our newest program for the fully insured market.” “The fourth quarter and full year results reflect strong revenue growth and margin expansion,” said Mark Livingston, Progyny’s Chief Financial Officer. “Under our latest share repurchase program, we acquired more than 3.3 million shares during the fourth quarter, and approximately 6.5 million shares to date, returning approximately $160 million in capital to our shareholders.” Fourth Quarter and Full Year 2025 Highlights: (unaudited; in thousands, except per share amounts)4Q2025 4Q2024 FY2025 FY2024Revenue$318,403 $298,431 $1,288,661 $1,167,221 Gross Profit$76,881 $63,432 $304,484 $253,363 Gross Margin 24.1% 21.3% 23.6% 21.7%Net Income$12,485 $10,532 $58,520 $54,336 Net Income per Diluted Share1$0.14 $0.12 $0.65 $0.57 Adjusted Earnings per Diluted Share2$0.48 $0.42 $1.89 $1.64 Adjusted EBITDA2$51,388 $47,514 $222,092 $198,760 Adjusted EBITDA Margin2 16....